{"questions":[{"id":"open_question-entities-pc12-cell-line-ad8d0a53","artifact_type":"open_question","title":"Microfluidic platforms","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-pc12-cell-line-ab4e1543","artifact_type":"open_question","title":"3D culture systems","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-pc12-cell-line-c86ceb2d","artifact_type":"open_question","title":"CRISPR screening","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-pc12-cell-line-f1dc1cd8","artifact_type":"open_question","title":"iPSC comparison","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-remternetug-d9ff1b81","artifact_type":"open_question","title":"Subcutaneous formulation:","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-remternetug-ea0979b7","artifact_type":"open_question","title":"Fixed-dose regimen:","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-remternetug-b34721d5","artifact_type":"open_question","title":"Biannual dosing:","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-prasinezumab-ae8f9089","artifact_type":"open_question","title":"Biomarker-driven selection","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-prasinezumab-836085b7","artifact_type":"open_question","title":"Genetic stratification","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-prasinezumab-e7904cbd","artifact_type":"open_question","title":"Disease stage optimization","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-prasinezumab-07030245","artifact_type":"open_question","title":"Multiple antibodies","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-prasinezumab-bf1df157","artifact_type":"open_question","title":"Small molecules","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-prasinezumab-e3ca0ff5","artifact_type":"open_question","title":"Cell replacement","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-prasinezumab-88564b05","artifact_type":"open_question","title":"Symptomatic drugs","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-prasinezumab-16a35d41","artifact_type":"open_question","title":"Clinical endpoints","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-prasinezumab-59194947","artifact_type":"open_question","title":"Biomarker endpoints","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-prasinezumab-132a773b","artifact_type":"open_question","title":"Digital biomarkers","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-prasinezumab-66cb274d","artifact_type":"open_question","title":"Composite endpoints","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-bnip1-protein-dcfd3a45","artifact_type":"open_question","title":"Cell type-specific functions","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-bnip1-protein-af249cb1","artifact_type":"open_question","title":"Post-translational modifications","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-bnip1-protein-c91ed076","artifact_type":"open_question","title":"Interorganellar communication","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-bnip1-protein-6b5fd37c","artifact_type":"open_question","title":"Therapeutic window","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-bnip1-protein-dc1d82f3","artifact_type":"open_question","title":"Biomarker potential","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-prx005-cbdbb5a6","artifact_type":"open_question","title":"Engineered Fc:","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-prx005-ee2fb201","artifact_type":"open_question","title":"Bispecific antibodies:","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-prx005-656cbc9e","artifact_type":"open_question","title":"Smaller formats:","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-prx005-bf0362bd","artifact_type":"open_question","title":"Gene therapy:","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-fcc7a854-474f-4420-adf3-2b133d39e36a","artifact_type":"open_question","title":"Which patient subgroups show tractable TrkB pathway insufficiency signatures?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:17.337966+00:00","updated_at":"2026-04-26T03:29:17.337966+00:00"},{"id":"open_question-0d88b0a2-faef-4657-9982-5c3d52ab3302","artifact_type":"open_question","title":"What target engagement threshold predicts durable synaptic rescue?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:17.387769+00:00","updated_at":"2026-04-26T03:29:17.387769+00:00"},{"id":"open_question-cd04a5bc-2be8-430a-89f2-914bf9516f66","artifact_type":"open_question","title":"How should TrkB therapies be sequenced with disease-specific upstream interventions?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:17.439772+00:00","updated_at":"2026-04-26T03:29:17.439772+00:00"},{"id":"open_question-e7186812-2b1f-43b1-a36d-bb1160b4b798","artifact_type":"open_question","title":"Which biomarkers best capture pathway activation in vivo?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:17.489966+00:00","updated_at":"2026-04-26T03:29:17.489966+00:00"},{"id":"open_question-3abd2840-f0ce-49f7-8009-7c0a0f81b2af","artifact_type":"open_question","title":"Can chronic pathway activation remain safe in older multimorbid populations?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:17.542390+00:00","updated_at":"2026-04-26T03:29:17.542390+00:00"},{"id":"open_question-eec891f9-2ffe-419c-bf9f-1ce96a31d1a1","artifact_type":"open_question","title":"Cell type-specific functions**: How does BNIP1 function differ between neurons, astrocytes, and microglia?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:18.034767+00:00","updated_at":"2026-04-26T03:29:18.034767+00:00"},{"id":"open_question-e7cf2ffc-e645-4277-b4ab-602c93bd22e9","artifact_type":"open_question","title":"Post-translational modifications**: How do phosphorylation, ubiquitination, and other modifications affect BNIP1 activity?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:18.087158+00:00","updated_at":"2026-04-26T03:29:18.087158+00:00"},{"id":"open_question-0a96a5ef-cae7-498b-a570-e9703769314f","artifact_type":"open_question","title":"Interorganellar communication**: How does BNIP1 coordinate ER-mitochondria contacts under different stress conditions?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:18.139717+00:00","updated_at":"2026-04-26T03:29:18.139717+00:00"},{"id":"open_question-5e6477f7-eadd-4b23-9d0b-15922500101b","artifact_type":"open_question","title":"Therapeutic window**: Can BNIP1 be safely modulated without disrupting normal cellular function?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:18.193531+00:00","updated_at":"2026-04-26T03:29:18.193531+00:00"},{"id":"open_question-37e9db36-5240-4aa9-bc9b-05aaf1b9553e","artifact_type":"open_question","title":"Biomarker potential**: Can BNIP1 expression or variants serve as biomarkers for neurodegenerative disease?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:18.247466+00:00","updated_at":"2026-04-26T03:29:18.247466+00:00"},{"id":"open_question-6f7e42cd-f63a-4808-8f15-ac3b664412ab","artifact_type":"open_question","title":"Mechanism of pathogenesis**: How do specific mutations lead to neurodegeneration?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:28.225288+00:00","updated_at":"2026-04-26T03:29:28.225288+00:00"},{"id":"open_question-9c9d4546-18ec-4473-b9d9-e7ba76c00690","artifact_type":"open_question","title":"Normal function**: What is the physiological role of LRRK2 in neurons?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:28.327268+00:00","updated_at":"2026-04-26T03:29:28.327268+00:00"},{"id":"open_question-0fd5c8d5-9ac6-4d12-9e97-3ac0011c1478","artifact_type":"open_question","title":"Biomarkers**: Can we develop LRRK2-specific biomarkers for clinical use?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:28.477106+00:00","updated_at":"2026-04-26T03:29:28.477106+00:00"},{"id":"open_question-81e082c5-982c-4a4e-80e9-a40cebafcc07","artifact_type":"open_question","title":"Therapeutic windows**: What is the optimal level of LRRK2 inhibition for benefit?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:28.595828+00:00","updated_at":"2026-04-26T03:29:28.595828+00:00"},{"id":"open_question-c5daf63d-16fa-4c4f-bc87-7eb5641383d8","artifact_type":"open_question","title":"Combination therapies**: What other targets should be combined with LRRK2 inhibition?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:28.690063+00:00","updated_at":"2026-04-26T03:29:28.690063+00:00"},{"id":"open_question-43be22e1-dd15-4162-ad42-f8093e2a53ab","artifact_type":"open_question","title":"Patient selection**: Which patients are most likely to benefit from LRRK2-targeted therapies?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:28.801070+00:00","updated_at":"2026-04-26T03:29:28.801070+00:00"},{"id":"open_question-entities-histamine-e8bfd62c","artifact_type":"open_question","title":"Peripheral vs. central histamine","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-histamine-ef294c49","artifact_type":"open_question","title":"Translation of preclinical findings","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-histamine-aa1766e1","artifact_type":"open_question","title":"Receptor subtype-specific effects","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-histamine-86748f9a","artifact_type":"open_question","title":"Temporal dynamics","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-sh-sy5y-c86ceb2d","artifact_type":"open_question","title":"CRISPR screening","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-sh-sy5y-ab4e1543","artifact_type":"open_question","title":"3D culture systems","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-sh-sy5y-10b9a1eb","artifact_type":"open_question","title":"Co-culture systems","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-sh-sy5y-27d10e5d","artifact_type":"open_question","title":"Microfluidic devices","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-sh-sy5y-5a8cf24c","artifact_type":"open_question","title":"Patient-derived models","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-lrrk2-567dca16","artifact_type":"open_question","title":"Patient selection","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-lrrk2-a1550f37","artifact_type":"open_question","title":"Mechanism of pathogenesis","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-lrrk2-b7abb6d5","artifact_type":"open_question","title":"Normal function","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-lrrk2-de764e13","artifact_type":"open_question","title":"Therapeutic windows","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-lrrk2-49402d63","artifact_type":"open_question","title":"Combination therapies","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-overview-16235965","artifact_type":"open_question","title":"Epigenetic Regulators","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-overview-8750337d","artifact_type":"open_question","title":"Non-Coding RNAs","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-overview-92e1cc5f","artifact_type":"open_question","title":"Metabolomic Entities","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-entities-overview-7d9103b7","artifact_type":"open_question","title":"Single-Cell Markers","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"}],"total":61,"limit":100,"offset":0,"returned":61,"sort":"importance_elo","field":"entities"}